Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371670 · ClinicalTrials.gov registry record · Phase 2
Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee
A Phase 2 study of Knee Osteoarthritis, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 223
- Enrollment target
- 2
- Study locations
NCT00371670: Completed Phase 2 study of Knee Osteoarthritis, sponsored by Novartis Pharmaceuticals.
NCT00371670 is a Phase 2 study of Knee Osteoarthritis that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 223 participants, below the 302-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (26% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00371670, a Phase 2 study of Knee Osteoarthritis, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 223 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will test efficacy and safety of AAE581 compared to placebo in limiting cartilage loss in patients with painful knee osteoarthritis which is confirmed by X-ray
Conditions Studied
Interventions
- DRUG balicatib (AAE581)
Study Locations (2)
Alabama
- Pinnacle Research Group - Anniston
Other
- Novartis - Nuremberg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2004-12 |
| Phase | Phase 2 |
What the finished NCT00371670 record still lists
NCT00371670 is an interventional study that assigns participants to a tested intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, below the 302-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which balicatib (AAE581) is the first listed.
NCT00371670 reports a single indexed study location in Alabama, Other.
Frequently Asked Questions
What is clinical trial NCT00371670 about?
NCT00371670 is a clinical study titled "Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee". This study will test efficacy and safety of AAE581 compared to placebo in limiting cartilage loss in patients with painful knee osteoarthritis which is confirmed by X-ray
What is the current status of trial NCT00371670?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 223 participants. The study started on 2004-12.
What conditions does trial NCT00371670 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT00371670?
The interventions under investigation include: balicatib (AAE581) (DRUG).
Who is sponsoring clinical trial NCT00371670?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00371670 being conducted?
This trial has 2 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00371670's enrollment target sits among peer trials
223 20th of 101 higher than 82 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis
RECRUITING · Phase 2
-
Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA
RECRUITING · Phase 2
-
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
RECRUITING · Phase 2
-
Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis
RECRUITING · Phase 2
-
A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees
COMPLETED · Phase 2
-
Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06640803 · 223 participants · NA
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
- NCT07175285 · 223 participants
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- NCT07205718 · 223 participants · Phase 1
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia